ID   KK-2
AC   CVCL_VK46
DR   Cosmic; 1085914
DR   JCRB; IFO50494
DR   Wikidata; Q94339858
RX   PubMed=1323907;
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=1323907).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=9738976).
CC   Discontinued: JCRB; IFO50494; true.
CC   Derived from site: In situ; Brain, occipital lobe; UBERON=UBERON_0002021.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
RX   PubMed=1323907; DOI=10.1007/BF00427215;
RA   Ito H., Kameya T., Suwa T., Wada C., Kawano N.;
RT   "A continuous cell line (KK-2) from a supratentorial primitive
RT   neuroectodermal tumor.";
RL   Acta Neuropathol. 84:52-58(1992).
//
RX   PubMed=9738976; DOI=10.1111/j.1349-7006.1998.tb03274.x; PMCID=PMC5921883;
RA   Urano F., Umezawa A., Yabe H., Hong W., Yoshida K., Fujinaga K.,
RA   Hata J.-i.;
RT   "Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF,
RT   available for diagnosis.";
RL   Jpn. J. Cancer Res. 89:703-711(1998).
//